Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

ASCO 2025: Metastatic breast cancer treatment highlights

Share :

ASCO 2025

30 May - 3 Jun 2025
Published: 2 Jun 2025
Views: 172
Rating:
Save
Dr Maryam Lustberg - Yale School of Medicine, New Haven, USA

Dr Lustberg gives an overview to ecancer on key breast cancer research abstracts from ASCO 2025.

  • Categories:

Related Videos

ASCO 2025: Latest updates in mRCC
Dr Michael Serzan, Dr Guillermo De Velasco, Dr Alessandro Rametta and Dr Javier...
ASCO 2025: Latest updates in mRCC ( Dr Michael Serzan, Dr Guillermo De Velasco, Dr Alessandro Rametta and Dr Javier Puente )
2 Jun 2025
New MOAs in prostate cancer treatment - what’s next?
Dr Joaquin Mateo, Dr Andrew Parsonson and Dr Capucine Baldini
New MOAs in prostate cancer treatment - what’s next? ( Dr Joaquin Mateo, Dr Andrew Parsonson and Dr Capucine Baldini )
2 Jun 2025
ELCC 2025: Latest in EGFR positive NSCLC
Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna...
ELCC 2025: Latest in EGFR positive NSCLC ( Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna Minchom )
25 Apr 2025
Dermatologic adverse events in the treatment of NSCLC with amivantamab plus...
Prof Nicolas Girard - Institut Curie, Paris, France
Dermatologic adverse events in the treatment of NSCLC with amivantamab plus lazertinib significantly reduced ( Prof Nicolas Girard - Institut Curie, Paris, France )
7 Apr 2025
Urine test could reduce post-op scans for kidney cancer by half
Dr Saeed Dabestani - Lund university, Lund, Sweden
Urine test could reduce post-op scans for kidney cancer by half ( Dr Saeed Dabestani - Lund university, Lund, Sweden )
27 Mar 2025
Micro-ultrasound is as effective as MRI in detecting prostate cancer
Dr Laurence Klotz - Sunnybrook Health Sciences Centre, Toronto, Canada
Micro-ultrasound is as effective as MRI in detecting prostate cancer ( Dr Laurence Klotz - Sunnybrook Health Sciences Centre, Toronto, Canada )
27 Mar 2025
Bone-protective agents given with enzalutamide with or without radium-223 show...
Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada
Bone-protective agents given with enzalutamide with or without radium-223 show greater survival benefits in mCRPC ( Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada )
27 Mar 2025
Darolutamide plus ADT provides deep and durable PSA responses in metastatic...
Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada
Darolutamide plus ADT provides deep and durable PSA responses in metastatic hormone-sensitive prostate cancer ( Prof Fred Saad - University of Montreal Hospital Center, Montreal, Canada )
27 Mar 2025
ASCO GU 2025: Latest updates in mRCC
Dr Bradley McGregor, Dr Stephanie Berg, Prof Viktor Grünwald and Prof Roberto...
ASCO GU 2025: Latest updates in mRCC ( Dr Bradley McGregor, Dr Stephanie Berg, Prof Viktor Grünwald and Prof Roberto Iacovelli )
19 Feb 2025

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation